PULSE BIOSCIENCES, INC. — Director's Dealing 2023

Nov 17, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2023-11-16

Reporting Person: Danahy Kevin Patrick (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-11-16	Common Stock	P	4781	$6.5199	Acquired	35275	Direct
2023-11-16	Common Stock	P	600	$6.51	Acquired	35875	Direct
2023-11-16	Common Stock	P	12	$6.50	Acquired	35887	Direct